Form 4: Guardant Health CFO Executes Restricted Stock Unit Vesting

Guardant Health CFO Michael Brian Bell acquired 2,039 shares via RSU vesting and withheld 1,096 shares for tax obligations.

Summary

• CFO Michael Brian Bell acquired 2,039 shares of common stock on June 15, 2026, through the vesting of restricted stock units (RSUs).
• The company withheld 1,096 shares to satisfy tax withholding obligations related to the vesting event.
• The transaction price for the tax withholding was $129.82 per share.
• Following these transactions, the reporting person holds 48,452 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents routine equity compensation management rather than a strategic or financial shift.

Positives

• The transaction reflects the standard vesting of equity compensation, aligning the executive's interests with long-term shareholder value.

Negatives

• None identified; this is a routine administrative transaction related to equity compensation.

Risks

• None identified; this is a routine administrative transaction related to equity compensation.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive compensation and does not indicate a change in corporate strategy or financial outlook.

Comparison to Industry Standards

• The transaction follows standard industry practices for executive equity compensation and tax withholding protocols.
• The vesting schedule is consistent with typical long-term incentive plans for C-suite executives in the biotechnology sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity vesting event.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Guardant Health, GH, CFO, Insider Trading, Form 4, Equity Compensation, Restricted Stock Units